The company will spin off the Bausch + Lomb Brand into a fully integrated, pure play eye-health company, and incorporate its other eye health product offerings into the new company.
Bausch Health will then focus on its gastroenterology, aesthetics/dermatology, neurology and pharmaceuticals businesses.
Company leadership said it wanted to spin the company off to “better enable stakeholders to value each business independently.”
More articles on specialty centers:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.